Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Vaccines

  Free Subscription


Articles published in Vaccine

Retrieve available abstracts of 1175 articles:
HTML format
Text format



Single Articles


    February 2012
  1. POLAND GA , Tosh PK
    New influenza vaccines: Promises, perils, and pitfalls.
    Vaccine. 2012;30:983-4.
    PubMed     Text format     Related articles   



    January 2012
  2. WANG F , Zhao YL, Ma JC, Bi SL, et al
    Long-term efficacy of 10-12 years after being immunized with Chinese hamster ovary cell derived hepatitis B vaccine in Chinese Rural Communities.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  3. KUHNERT R , Schlaud M, Poethko-Muller C, Vennemann M, et al
    Reanalyses of case-control studies examining the temporal association between sudden infant death syndrome and vaccination.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  4. MCELHANEY JE , Zhou X, Talbot HK, Soethout E, et al
    The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  5. WALLEMACQ H , Bedoret D, Pujol J, Desmet C, et al
    CD40 triggering induces strong cytotoxic T lymphocyte responses to heat-killed Staphylococcus aureus immunization in mice: A new vaccine strategy for staphylococcal mastitis.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  6. ROOS TB , de Lara AP, Dummer LA, Fischer G, et al
    The immune modulation of Bacillus cereus var. Toyoi in mice immunized with experimental inactivated Bovine Herpesvirus Type 5 vaccine.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  7. KIM S , Zuiani A, Carrero JA, Hansen TH, et al
    Single chain MHC I trimer-based DNA vaccines for protection against Listeria monocytogenes infection.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  8. FABRIZI F , Dixit V, Messa P, Martin P, et al
    Hepatitis B virus vaccine in chronic kidney disease: Improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  9. OVSYANNIKOVA IG , Shane Pankratz V, Vierkant RA, Jacobson RM, et al
    Consistency of HLA associations between two independent measles vaccine cohorts: A replication study.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  10. JOHNSON DR , D'Onise K, Holland RA, Raupach JC, et al
    Pneumococcal disease in South Australia: Vaccine success but no time for complacency.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  11. VEEN RL , Loynachan AT, Mogler MA, Russell BJ, et al
    Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  12. ZHOU M , Kostoula I, Brill B, Panou E, et al
    Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  13. SHEARER JD , Manetz TS, House RV
    Preclinical safety assessment of recombinant botulinum vaccine A/B (rBV A/B).
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  14. CASTANEDA-ORJUELA C , Alvis-Guzman N, Gonzalez MV, De la Hoz-Restrepo F, et al
    Cost-effectiveness of pneumococcal conjugate vaccines of 7, 10, and 13 valences in Colombian children.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  15. LI Y , Li P, Wang X, Yu Q, et al
    Co-administration of attenuated Mycoplasma hyopneumoniae 168 strain with bacterial DNA enhances the local and systemic immune response after intranasal vaccination in pigs.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  16. ARROSSI S , Maceira V, Paolino M, Sankaranarayan R, et al
    Acceptability and uptake of HPV vaccine in Argentina before its inclusion in the immunization program: A population-based survey.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  17. KENNEDY RB , Ovsyannikova IG, Haralambieva IH, O'Byrne M, et al
    Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  18. BUCZKOWSKI H , Parida S, Bailey D, Barrett T, et al
    A novel approach to generating morbillivirus vaccines: Negatively marking the rinderpest vaccine.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  19. BAUER M , Georgousakis M, Vu T, Henningham A, et al
    Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-protein.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  20. BECK CR , Cloke R, O'Moore E, Puleston R, et al
    Hepatitis B vaccination coverage and uptake in prisons across England and Wales 2003-2010: A retrospective ecological study.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  21. HUANG WT , Huang WI, Huang YW, Hsu CW, et al
    The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: A capture-recapture analysis.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  22. COX MM
    Recombinant protein vaccines produced in insect cells.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  23. GAFFGA NH , Flagg EW, Weinstock HS, Shlay JC, et al
    Monitoring HPV type-specific prevalence over time through clinic-based surveillance: A perspective on vaccine effectiveness.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  24. LIAO Q , Strong AJ, Liu Y, Liu Y, et al
    HIV vaccine candidates generate in vitro T cell response to putative epitopes in Chinese-origin rhesus macaques.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  25. BOUDREAU EF , Josleyn M, Ullman D, Fisher D, et al
    A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  26. KIM KH , Kim YK, Kim NH, Chang SH, et al
    Immunogenicity and safety of LBVH0101, a new Haemophilus influenzae type b tetanus toxoid conjugate vaccine, compared with Hiberix in Korean infants and children: A randomized trial.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  27. IORIO AM , Bistoni O, Galdiero M, Lepri E, et al
    Influenza viruses and cross-reactivity in healthy adults: Humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  28. POLISENA J , Chen Y, Manuel D
    The proportion of influenza vaccination in Ontario, Canada in 2007/2008 compared with other provinces.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  29. FRAILE L , Grau-Roma L, Sarasola P, Sinovas N, et al
    Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: Improvement of production parameters and interaction with maternally derived immunity.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  30. RODRIGUEZ-MALLON A , Fernandez E, Encinosa PE, Bello Y, et al
    A novel tick antigen shows high vaccine efficacy against the dog tick, Rhipicephalus sanguineus.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  31. SHANG S , Shanley CA, Caraway ML, Orme EA, et al
    Drug treatment combined with BCG vaccination reduces disease reactivation in guinea pigs infected with Mycobacterium tuberculosis.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  32. TACHIBANA M , Sato C, Otsuki H, Sattabongkot J, et al
    Plasmodium vivax gametocyte protein Pvs230 is a transmission-blocking vaccine candidate.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  33. BEQUET-ROMERO M , Morera Y, Ayala-Avila M, Ancizar J, et al
    CIGB-247: A VEGF-based therapeutic vaccine that reduces experimental and spontaneous lung metastasis of C57Bl/6 and BALB/c mouse tumors.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  34. NJONGMETA LM , Bray J, Davies CJ, Davis WC, et al
    CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4(+) T cell responses following DNA vaccination of outbred animals.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  35. FU J , Zhao B, Dong Z, Sun Y, et al
    Heparanase DNA vaccine delivered by electroporation induces humoral immunity and cytoimmunity in animal models.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  36. COUPE VM , Bogaards JA, Meijer CJ, Berkhof J, et al
    Impact of vaccine protection against multiple HPV types on the cost-effectiveness of cervical screening.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  37. ZHOU H , Min J, Zhao Q, Gu Q, et al
    Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  38. HAGHI F , Peerayeh SN, Siadat SD, Zeighami H, et al
    Recombinant outer membrane secretin PilQ(406-770) as a vaccine candidate for serogroup B Neisseria meningitidis.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  39. GOICOCHEA MA , Zapata JC, Bryant J, Davis H, et al
    Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse model.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  40. CONNOLLY T , Reb J
    Toward interactive, Internet-based decision aid for vaccination decisions: Better information alone is not enough.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  41. COX JH , Ferrari MG, Earl P, Lane JR, et al
    Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  42. OPEL DJ , Robinson JD, Heritage J, Korfiatis C, et al
    Characterizing providers' immunization communication practices during health supervision visits with vaccine-hesitant parents: A pilot study.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  43. HIROBE S , Matsuo K, Quan YS, Kamiyama F, et al
    Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheria.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  44. STEWART B , Zhang Y, Rose Jr CE, Tokars JI, et al
    Health-related quality of life in the anthrax vaccination program for workers in the laboratory response network.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  45. BROWN KF , Long SJ, Ramsay M, Hudson MJ, et al
    UK parents' decision-making about measles-mumps-rubella (MMR) vaccine 10 years after the MMR-autism controversy: A qualitative analysis.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  46. FLACH CF , Mozer M, Sundquist M, Holmgren J, et al
    Mucosal vaccination increases local chemokine production attracting immune cells to the stomach mucosa of Helicobacter pylori infected mice.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  47. SHEN SS , Yang YW
    Antigen delivery for cross priming via the emulsion vaccine adjuvants.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  48. TANABE K , Arisue N, Palacpac NM, Yagi M, et al
    Geographic differentiation of polymorphism in the Plasmodium falciparum malaria vaccine candidate gene SERA5.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  49. WHITE OJ , McKenna KL, Bosco A, van den Biggelaar A, et al
    A genomics-based approach to assessment of vaccine safety and immunogenicity in children.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  50. OUANDAOGO CR , Yameogo TM, Diomande FV, Sawadogo C, et al
    Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  51. KOLLIPARA A , George C, Hanger J, Loader J, et al
    Vaccination of healthy and diseased koalas (Phascolarctos cinereus) with a Chlamydia pecorum multi-subunit vaccine: Evaluation of immunity and pathology.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  52. LEKCHAROENSUK P , Wiriyarat W, Petcharat N, Lekcharoensuk C, et al
    Cloned cDNA of A/swine/Iowa/15/1930 internal genes as a candidate backbone for reverse genetics vaccine against influenza A viruses.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  53. SNAPE MD , Medini D, Halperin SA, Detora L, et al
    The challenge of post-implementation surveillance for novel meningococcal vaccines.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  54. GARCEL A , Fauquette W, Dehouck MP, Crance JM, et al
    Vaccinia virus-induced smallpox postvaccinal encephalitis in case of blood-brain barrier damage.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  55. POLAND GA , Jacobson RM
    The re-emergence of measles in developed countries: Time to develop the next-generation measles vaccines?
    Vaccine. 2012;30:103-4.
    PubMed     Text format     Related articles   



  56. MINERVINI G , McCarson BJ, Reisinger KS, Martin JC, et al
    Safety and immunogenicity of a modified process hepatitis B vaccine in healthy neonates.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  57. SEKI M , Udagawa T, Sugawara I, Iwama K, et al
    The effect of passages during Japanese BCG vaccine production on genetic stability and protective efficacy.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  58. WINKELMANN ER , Widman DG, Xia J, Ishikawa T, et al
    Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  59. REED C , Meltzer MI, Finelli L, Fiore A, et al
    Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  60. NEVIN RL
    Confounding and bias in studies of DMSS vaccination data.
    Vaccine. 2012.
    PubMed     Text format     Related articles   



  61. GOWDA C , Dempsey AF
    Medicaid reimbursement and the uptake of adolescent vaccines.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  62. CHLIBEK R , Anca I, Andre F, Cizman M, et al
    Adult vaccination in 11 Central European countries - Calendars are not just for children.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  63. RAINEY JJ , Lacapere F, Danovaro-Holliday MC, Mung K, et al
    Vaccination coverage in Haiti: Results from the 2009 National Survey.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  64. PANDYA J , Gorchakov R, Wang E, Leal G, et al
    A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



  65. FANG X , Zhang S, Sun X, Li J, et al
    Evaluation of attenuated VSVs with mutated M or/and G proteins as vaccine vectors.
    Vaccine. 2012.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  66. BRIEN S , Kwong JC, Buckeridge DL
    The determinants of 2009 pandemic A/H1N1 influenza vaccination: A systematic review.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  67. MOHLER VL , Heithoff DM, Mahan MJ, Hornitzky MA, et al
    Development of a novel in-water vaccination protocol for DNA adenine methylase deficient Salmonella enterica serovar Typhimurium vaccine in adult sheep.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  68. KRISHNARAJAH G , Davis EJ, Fan Y, Standaert BA, et al
    Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  69. EL-ATTAR L , Scott S, Goh S, Good L, et al
    A pestivirus DNA vaccine based on a non-antibiotic resistance Escherichia coli essential gene marker.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  70. WESTON WM , Friedland LR, Wu X, Howe B, et al
    Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix((R))): Results of two randomized trials.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  71. YIM K , Miles B, Zinsou R, Prince G, et al
    Efficacy of trivalent inactivated influenza vaccines in the cotton rat Sigmodon hispidus model.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  72. ZENG Q , Gomez BP, Viscidi RP, Peng S, et al
    Development of a DNA vaccine targeting Merkel cell polyomavirus.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  73. DEKKER CN , Bouma A, Daemen AJ, van Leengoed LA, et al
    Homologous whole bacterin vaccination is not able to reduce Streptococcus suis serotype 9 strain 7997 transmission among pigs or colonization.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  74. THOMAS B , Nishikawa S, Ito K, Chopra P, et al
    Peptide vaccination is superior to genetic vaccination using a recombineered bacteriophage lambda subunit vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  75. SPIER R
    Meeting report: 1st Middle East Vaccine Congress, 17-19th November, 2011 at Abu Dhabi, UAE.
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  76. MARTINO A , Magagnoli C, De Conciliis G, D'Ascenzi S, et al
    Structural characterisation, stability and antibody recognition of chimeric NHBA-GNA1030: An investigational vaccine component against Neisseria meningitidis.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  77. HUNG IF , Levin Y, To KK
    Quantitative and qualitative analysis of antibody response after dose sparing intradermal 2009 H1N1 vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  78. CAMPBELL SA , Alawa J, Doro B, Henriquez FL, et al
    Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  79. MOULIN V , Noordegraaf CV, Makoschey B, van der Sluijs M, et al
    Clinical disease in sheep caused by bluetongue virus serotype 8, and prevention by an inactivated vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  80. SEREGIN SS , Aldhamen YA, Rastall DP, Godbehere S, et al
    Adenovirus-based vaccination against Clostridium difficile toxin A allows for rapid humoral immunity and complete protection from toxin A lethal challenge in mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  81. CHRISTY AJ , Dharman K, Dhandapaani G, Palaniyandi K, et al
    Epitope based recombinant BCG vaccine elicits specific Th1 polarized immune responses in BALB/c mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  82. NEWES-ADEYI G , Greece J, Bozeman S, Walker DK, et al
    Active surveillance for influenza vaccine adverse events: The integrated vaccine surveillance system.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  83. STOCK NK , Boschetti N, Herzog C, Appelhans MS, et al
    The phylogeny of yellow fever virus 17D vaccines.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  84. HUANG LM , Lin TY, Juergens C
    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccines in Taiwan.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  85. BEYER HL , Hampson K, Lembo T, Cleaveland S, et al
    The implications of metapopulation dynamics on the design of vaccination campaigns.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  86. BEGIN P , Roches AD
    Nicolau syndrome may be caused by intravascular vaccine injection.
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  87. FIELD RI , Caplan AL
    Evidence-based decision making for vaccines: The need for an ethical foundation.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  88. HEININGER U , Bachtiar NS, Bahri P, Dana A, et al
    The concept of vaccination failure.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  89. WERTHEIMER ER , Olive DS, Brundage JF, Clark LL, et al
    Contact transmission of vaccinia virus from smallpox vaccinees in the United States, 2003-2011.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  90. BETSCH C , Wicker S
    E-health use, vaccination knowledge and perception of own risk: Drivers of vaccination uptake in medical students.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  91. HARRO CD , Betts RF, Hartzel JS, Onorato MT, et al
    The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): Results of two Phase I studies.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  92. JUN L , Jie L, Dongping Y, Xin Y, et al
    Effects of nasal immunization of multi-target preventive vaccines on atherosclerosis.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  93. VESIKARI T , Forsten A, Herbinger KH, Cioppa GD, et al
    Safety and immunogenicity of an MF59((R))-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  94. AN SJ , Yoon YK, Kothari S, Kim DR, et al
    Immune suppression induced by Vi capsular polysaccharide is overcome by Vi-DT conjugate vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  95. RIMOIN AW , Graham BS
    Whither Monkeypox vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  96. VENKATASWAMY MM , Goldberg MF, Baena A, Chan J, et al
    In vitro culture medium influences the vaccine efficacy of Mycobacterium bovis BCG.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  97. HODGINS DC , Shewen PE
    Vaccination of neonates: Problem and issues.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  98. NOSSAL GJ
    Vaccines of the future.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  99. SHCHELKUNOV SN
    Emergence and reemergence of smallpox: The need in development of a new generation smallpox vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  100. SCHATZMAYR HG , Costa RV, Goncalves MC, D'Andrea PS, et al
    Human and animal infections by vaccinia-like viruses in the state of Rio de Janeiro: A novel expanding zoonosis.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  101. TANG J , Yin R, Tian Y, Huang Z, et al
    A novel self-assembled nanoparticle vaccine with HIV-1 Tat(49-57)/HPV16 E7(49-57) fusion peptide and GM-CSF DNA elicits potent and prolonged CD8(+) T cell-dependent anti-tumor immunity in mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  102. NISHIZAWA T , Gye HJ, Takami I, Oh MJ, et al
    Potentiality of a live vaccine with nervous necrosis virus (NNV) for sevenband grouper Epinephelus septemfasciatus at a low rearing temperature.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  103. LAI L , Kwa SF, Kozlowski PA, Montefiori DC, et al
    SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  104. HARDELID P , Fleming DM, Andrews N, Barley M, et al
    Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: Results from a cohort study in general practice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  105. MURPHY D , Marteau TM, Wessely S
    A longitudinal study of UK military personnel offered anthrax vaccination: Informed choice, symptom reporting, uptake and pre-vaccination health.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  106. TOH MP , Kannan P, Chen Y, Chng FL, et al
    Healthcare workers and H1N1 vaccination: Does having a chronic disease make a difference?
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  107. GUTHMANN JP , Fonteneau L, Bonmarin I, Levy-Bruhl D, et al
    Influenza vaccination coverage one year after the A(H1N1) influenza pandemic, France, 2010-2011.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  108. KHAWPLOD P , Jaijaroensup W, Sawangvaree A, Prakongsri S, et al
    One clinic visit for pre-exposure rabies vaccination (a preliminary one year study).
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  109. MATSUSHITA M , Takeuchi S, Kumagai N, Uehara Y, et al
    Prevaccination antibody titers can estimate the immune response to influenza vaccine in a rural community-dwelling elderly population.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  110. WITTEMAN HO , Zikmund-Fisher BJ
    The defining characteristics of Web 2.0 and their potential influence in the online vaccination debate.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  111. LERTDUMRONGLUK P , Changsirikulchai S, Limkunakul C, Prachukthum P, et al
    Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  112. FRITZ R , Orlinger KK, Hofmeister Y, Janecki K, et al
    Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  113. VAN RIJSWOUD E
    Reply to "Preparing for the next public debate: Universal vaccination against hepatitis B"Vaccine 29 (8 November 2011), pp. 8960-8964.
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  114. DAVIS RL
    The vaccine adverse event reporting system and vaccine safety research in the genomics era.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  115. KARRON RA , Thumar B, Schappell E, Surman S, et al
    Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  116. AZZARI C , Moriondo M, Cortimiglia M, Valleriani C, et al
    Potential serotype coverage of three pneumococcal conjugate vaccines against invasive pneumococcal infection in Italian children.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  117. CARRARO G , Naso A, Montomoli E, Gasparini R, et al
    Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: A pilot study.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  118. MANSILLA FC , Franco-Mahecha OL, Lavoria MA, Moore DP, et al
    The immune enhancement of a novel soy lecithin/beta-glucans based adjuvant on native Neospora caninum tachyzoite extract vaccine in mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  119. BREWOO JN , Kinney RM, Powell TD, Arguello JJ, et al
    Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  120. WEN K , Li G, Bui T, Liu F, et al
    High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  121. PITMAN RJ , White LJ, Sculpher M
    Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  122. GIAQUINTO C , Jackson AE, Vesikari T
    Report of the Second European Expert Meeting on Rotavirus Vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  123. MATYSIAK-KLOSE D , Ahmed F, Duclos P, Falck-Ytter Y, et al
    Report on the 1st international workshop on procedures for the development of evidence-based vaccination recommendations, Berlin, Germany, 22-23 November 2010.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  124. CHABOT DJ , Joyce J, Caulfield M, Cook J, et al
    Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeys.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  125. NAITO S , Ito Y, Kiyohara T, Kataoka M, et al
    Antigen-loaded dissolving microneedle array as a novel tool for percutaneous vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  126. NOUIR NB , Eschbach ML, Piedavent M, Osterloh A, et al
    Vaccination with Strongyloides ratti heat shock protein 60 increases susceptibility to challenge infection by induction of Th1 response.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  127. MCREE AL , Reiter PL, Brewer NT
    Parents' Internet use for information about HPV vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  128. KATA A
    Anti-vaccine activists, Web 2.0, and the postmodern paradigm - An overview of tactics and tropes used online by the anti-vaccination movement.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  129. MICOLI F , Rondini S, Pisoni I, Giannelli C, et al
    Production of a conjugate vaccine for Salmonella enterica serovar Typhi from Citrobacter Vi.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  130. EHRLICH HJ , Berezuk G, Fritsch S, Aichinger G, et al
    Clinical development of a Vero cell culture-derived seasonal influenza vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  131. ROPERO-ALVAREZ AM , Whittembury A, Kurtis HJ, Dos Santos T, et al
    Pandemic influenza vaccination: Lessons learned from Latin America and the Caribbean.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  132. HAKIM H , Allison KJ, Van De Velde LA, Li Y, et al
    Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  133. AMBROSE CS , Wu X, Knuf M, Wutzler P, et al
    The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  134. JOSE PRIYA TA , Lin YH, Wang YC, Yang CS, et al
    Codon changed immobilization antigen (iAg), a potent DNA vaccine in fish against Cryptocaryon irritans infection.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  135. SANDER BB , Rebolj M, Valentiner-Branth P, Lynge E, et al
    Introduction of human papillomavirus vaccination in Nordic countries.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  136. SANCHEZ-PAYA J , Hernandez-Garcia I, Garcia-Roman V, Camargo-Angeles R, et al
    Influenza vaccination among healthcare personnel after pandemic influenza H1N1.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  137. BAHEY-EL-DIN M
    Lactococcus lactis-based vaccines from laboratory bench to human use: An overview.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  138. KIM EH , Choi SY, Kwon MK, Tran TD, et al
    Streptococcus pneumoniae pep27 mutant as a live vaccine for serotype-independent protection in mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  139. VERMEULEN JN , Lange JM, Tyring SK, Peters PH, et al
    Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults >/=60 years of age.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  140. MAKOSCHEY B , Ramage C, Reddick D, Fraser S, et al
    Colostrum from cattle immunized with a vaccine based on iron regulated proteins of Mannheimia haemolytica confers partial protection.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  141. KANAGAVELU SK , Snarsky V, Termini JM, Gupta S, et al
    Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  142. CHANG JY , Chang CP, Tsai HH, Lee CD, et al
    Selection and characterization of vaccine strain for Enterovirus 71 vaccine development.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  143. AMOUR S , Voirin N, Regis C, Bouscambert-Duchamp M, et al
    Influenza vaccine effectiveness among adult patients in a University of Lyon hospital (2004-2009).
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  144. ZOLLINGER WD , Babcock JG, Moran EE, Brandt BL, et al
    Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  145. DELL'ERA L , Corona F, Daleno C, Scala A, et al
    Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  146. DEN BROK MH , Nierkens S, Wagenaars JA, Ruers TJ, et al
    Saponin-based adjuvants create a highly effective anti-tumor vaccine when combined with in situ tumor destruction.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  147. NICOLSON C , Harvey R, Johnson R, Guilfoyle K, et al
    An additional oligosaccharide moiety in the HA of a pandemic influenza H1N1 candidate vaccine virus confers increased antigen yield in eggs.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  148. SANTIBANEZ TA , Shefer A, Briere EC, Cohn A, et al
    Effects of a nationwide Hib vaccine shortage on vaccination coverage in the United States.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  149. NAKAJIMA H , Oka Y, Tsuboi A, Tatsumi N, et al
    Enhanced tumor immunity of WT1 peptide vaccination by interferon-beta administration.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  150. SAMMON CJ , McGrogan A, Snowball J, de Vries CS, et al
    Factors associated with uptake of seasonal and pandemic influenza vaccine among clinical risk groups in the UK: An analysis using the General Practice Research Database.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  151. KAUFMAN DR , Li F, Cruz AN, Self SG, et al
    Focus and breadth of cellular immune responses elicited by a heterologous insert prime-boost vaccine regimen in rhesus monkeys.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  152. ATKINS KE , Shim E, Pitzer VE, Galvani AP, et al
    Impact of rotavirus vaccination on epidemiological dynamics in England and Wales.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  153. REYNA VF
    Risk perception and communication in vaccination decisions: A fuzzy-trace theory approach.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  154. CASTILLA J , Beristain X, Martinez-Artola V, Navascues A, et al
    Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  155. PINTO VV , Salanti A, Joergensen LM, Dahlback M, et al
    The effect of adjuvants on the immune response induced by a DBL4varepsilon-ID4 VAR2CSA based Plasmodium falciparum vaccine against placental malaria.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  156. ASKLING HH , Vene S, Rombo L, Lindquist L, et al
    Immunogenicity of delayed TBE-vaccine booster.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  157. BILCKE J , Marais C, Ogunjimi B, Willem L, et al
    Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium.
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  158. SHARMA HJ , Patil VD, Lalwani SK, Mangalani MV, et al
    Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  159. SALVADOR A , Igartua M, Hernandez RM, Pedraz JL, et al
    Combination of immune stimulating adjuvants with poly(lactide-co-glycolide) microspheres enhances the immune response of vaccines.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  160. VON GOTTBERG A , Cohen C, Whitelaw A, Chhagan M, et al
    Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  161. LAVINE J , Bjornstad O, de Blasio BF, Storsaeter J, et al
    Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  162. KELLY H , Mercer G, Cowling BJ
    The association of seasonal influenza vaccination with pandemic influenza H1N1 2009 infection.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  163. ZHANG TT , Kang TH, Ma B, Xu Y, et al
    LAH4 enhances CD8+ T cell immunity of protein/peptide-based vaccines.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  164. PARLANE NA , Compton BJ, Hayman CM, Painter GF, et al
    Phosphatidylinositol di-mannoside and derivates modulate the immune response to and efficacy of a tuberculosis protein vaccine against Mycobacterium bovis infection.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  165. PEREIRA JA , Quach S, Hamid JS, Heidebrecht CL, et al
    Exploring the feasibility of integrating barcode scanning technology into vaccine inventory recording in seasonal influenza vaccination clinics.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  166. JONES BG , Sealy R, Rudraraju R, Traina-Dorge V, et al
    Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  167. VAN HOEK AJ , Melegaro A, Gay N, Bilcke J, et al
    The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  168. PATEL A , Gray M, Li Y, Kobasa D, et al
    Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  169. DORELL CG , Stokley S, Yankey D, Markowitz LE, et al
    Compliance with recommended dosing intervals for HPV vaccination among females, 13-17 years, National Immunization Survey-Teen, 2008-2009.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  170. BERZOFSKY JA
    A push-pull vaccine strategy using Toll-like receptor ligands, IL-15, and blockade of negative regulation to improve the quality and quantity of T cell immune responses.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  171. HALPERIN SA , Scheifele D, De Serres G, Noya F, et al
    Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous dose.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  172. PROCTOR R
    Is there a future for a Staphylococcus aureus vaccine?
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  173. TIRO JA , Pruitt SL, Bruce CM, Persaud D, et al
    Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  174. CLAUS H , Jordens MS, Kriz P, Musilek M, et al
    Capsule null locus meningococci: Typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  175. QUAN FS , Compans RW, Kang SM
    Oral vaccination with inactivated influenza vaccine induces cross-protective immunity.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  176. OSTERGAARD L , Silfverdal SA, Berglund J, Flodmark CE, et al
    A tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when co-administered with Twinrix((R)) in subjects aged 11-17 years: An open, randomised, controlled trial.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  177. ZHU D , Huang S, McClellan H, Dai W, et al
    Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  178. VAN DER SLUIJS MT , Schroer-Joosten DP, Fid-Fourkour A, Vrijenhoek MP, et al
    Effect of vaccination with an inactivated vaccine on transplacental transmission of BTV-8 in mid term pregnant ewes and heifers.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  179. KIS EE , Winter G, Myschik J
    Devices for intradermal vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  180. CASTILLA J , Martinez-Artola V, Salcedo E, Martinez-Baz I, et al
    Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: Cohort and case-control study.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  181. POLJAK A , Comstedt P, Hanner M, Schuler W, et al
    Identification and characterization of Borrelia antigens as potential vaccine candidates against Lyme borreliosis.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  182. SEYLER T , Bella A, Puzelli S, Donatelli I, et al
    Estimating pandemic vaccine effectiveness in two Italian regions using the screening method, 2009-2010.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  183. HORACIO AN , Diamantino-Miranda J, Aguiar SI, Ramirez M, et al
    Serotype changes in adult invasive pneumococcal infections in Portugal did not reduce the high fraction of potentially vaccine preventable infections.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  184. KOFF WC
    HIV vaccine development: Challenges and opportunities towards a solution of the HIV vaccine-neutralizing antibody problem.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  185. HERMANSON G , Chun S, Felgner J, Tan X, et al
    Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax((R)) using proteome microarrays and development of recombinant protein ELISAs.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  186. LINHART B , Valenta R
    Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  187. NELSON K , Janssen JM, Troy SB, Maldonado Y, et al
    Intradermal fractional dose inactivated polio vaccine: A review of the literature.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  188. NILSSON L , Lepp T, von Segebaden K, Hallander H, et al
    Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: Analyses of 10 years of pertussis surveillance.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  189. LIANG BA , Mackey TK
    Vaccine shortages and suspect online pharmacy sellers.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  190. GAUTRET P , Parola P
    Rabies vaccination for international travelers.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  191. PAVOT V , Rochereau N, Genin C, Verrier B, et al
    New insights in mucosal vaccine development.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  192. PARIS R , Bejrachandra S, Thongcharoen P, Nitayaphan S, et al
    HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX((R)) B/E.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  193. DUTHIE MS , Raman VS, Piazza FM, Reed SG, et al
    The development and clinical evaluation of second-generation leishmaniasis vaccines.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  194. TAN JL , Ueda N, Heath D, Mercer AA, et al
    Development of orf virus as a bifunctional recombinant vaccine: Surface display of Echinococcus granulosus 95 antigen by fusion to membrane structural proteins.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  195. GARCIA S , Lagos R, Munoz A, Picon T, et al
    Impact of vaccination against Haemophilus influenzae type b with and without a booster dose on meningitis in four South American countries.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  196. ALMAZAN C , Moreno-Cantu O, Moreno-Cid JA, Galindo RC, et al
    Control of tick infestations in cattle vaccinated with bacterial membranes containing surface-exposed tick protective antigens.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  197. PORTER KR , Ewing D, Chen L, Wu SJ, et al
    Immunogenicity and protective efficacy of a vaxfectin-adjuvanted tetravalent dengue DNA vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  198. KING JC JR , Beckett D, Snyder J, Cummings GE, et al
    Direct and indirect impact of influenza vaccination of young children on school absenteeism.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  199. DONG L , Liu F, Fairman J, Hong DK, et al
    Cationic liposome-DNA complexes (CLDC) adjuvant enhances the immunogenicity and cross-protective efficacy of a pre-pandemic influenza A H5N1 vaccine in mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  200. UCAKAR V , Poljak M, Klavs I
    Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: A cervical cancer screening based study.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  201. TAMBYAH PA , Wilder-Smith A, Pavlova BG, Barrett PN, et al
    Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  202. CHERUKURI A , Servat E, Woo J
    Vaccine-specific antibody secreting cells are a robust early marker of LAIV-induced B-cell response in ferrets.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  203. CASTRO-DIAZ N , Salaun B, Perret R, Sierro S, et al
    Saponins from the Spanish saffron Crocus sativus are efficient adjuvants for protein-based vaccines.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  204. HUIJBERS EJ , Femel J, Andersson K, Bjorkelund H, et al
    The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B-A prerequisite for clinical development.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  205. MIYATA T , Cheigh CI, Casali N, Goodridge A, et al
    An adjunctive therapeutic vaccine against reactivation and post-treatment relapse tuberculosis.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  206. CARREON D , Perez de la Lastra JM, Almazan C, Canales M, et al
    Vaccination with BM86, subolesin and akirin protective antigens for the control of tick infestations in white tailed deer and red deer.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  207. SHEN CF , Lanthier S, Jacob D, Montes J, et al
    Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3).
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  208. BJORKSTEN B
    Diverse microbial exposure - Consequences for vaccine development.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  209. DUDERSTADT SK , Rose CE Jr, Real TM, Sabatier JF, et al
    Vaccination and risk of type 1 diabetes mellitus in active component U.S. Military, 2002-2008.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  210. MUANGCHANA C , Henprasertthae N, Nurach K, Theppang K, et al
    Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: A case-control study.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  211. BROWN TH , David J, Acosta-Ramirez E, Moore JM, et al
    Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  212. TRAN TQ , Grimes CZ, Lai D, Troisi CL, et al
    Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  213. MORERA Y , Bequet-Romero M, Ayala M, Perez PP, et al
    Antigen dose escalation study of a VEGF-based therapeutic cancer vaccine in non human primates.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  214. LU CY , Santosham M
    Survey of national immunization programs and vaccine coverage rates in Asia Pacific countries.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  215. VELKERS FC , Bouma A, Stegeman JA, de Jong MC, et al
    Transmission of a live Eimeria acervulina vaccine strain and response to infection in vaccinated and contact-vaccinated broilers.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  216. SMITH JH , Papania M, Knaus D, Brooks P, et al
    Nebulized live-attenuated influenza vaccine provides protection in ferrets at a reduced dose.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  217. LOEB M , Russell ML, Fonseca K, Webby R, et al
    Comparison of multiple estimates of efficacy for influenza vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  218. KAPPES MA , Sandbulte MR, Platt R, Wang C, et al
    Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  219. OURA CA , Edwards L, Batten CA
    Evaluation of the humoral immune response in adult dairy cattle three years after vaccination with a bluetongue serotype 8 inactivated vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  220. HENDRIKX LH , Felderhof MK, Ozturk K, de Rond LG, et al
    Enhanced memory B-cell immune responses after a second acellular pertussis booster vaccination in children 9 years of age.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  221. ZHAO Z , Murphy TV, Jacques-Carroll L
    Progress in newborn hepatitis B vaccination by birth year cohorts-1998-2007, USA.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  222. LINHARES DC , Cano JP, Wetzell T, Nerem J, et al
    Effect of modified-live porcine reproductive and respiratory syndrome virus (PRRSv) vaccine on the shedding of wild-type virus from an infected population of growing pigs.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  223. GILCA V , De Serres G, Hamelin ME, Boivin G, et al
    Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  224. CAI Z , Zhang T, Wan XF
    Antigenic distance measurements for seasonal influenza vaccine selection.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  225. SACADURA-LEITE E , Sousa-Uva A, Rebelo-de-Andrade H
    Antibody response to the influenza vaccine in healthcare workers.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  226. KLEIN NP , Weston WM, Kuriyakose S, Kolhe D, et al
    An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP-IPV (Kinrix) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  227. KONIG P , Blome S, Gabriel C, Reimann I, et al
    Innocuousness and safety of classical swine fever marker vaccine candidate CP7_E2alf in non-target and target species.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



    October 2011
  228. HONG SH , Byun YH, Nguyen CT, Kim SY, et al
    Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  229. JACOBSEN SJ , Poland GA
    Methods in vaccine effectiveness and safety studies: A critical need for vaccine confidence.
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  230. LEE SW , Devlin JM, Markham JF, Noormohammadi AH, et al
    Comparative analysis of the complete genome sequences of two Australian origin live attenuated vaccines of infectious laryngotracheitis virus.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  231. ZHAO X , Fan Y, Wang D, Hu Y, et al
    Immunological adjuvant efficacy of glycyrrhetinic acid liposome against Newcastle disease vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  232. REDELINGS MD , Piron J, Smith LV, Chan A, et al
    Knowledge, attitudes, and beliefs about seasonal influenza and H1N1 vaccinations in a low-income, public health clinic population.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  233. CHAVES SS , Daniels D, Cooper BW, Malo-Schlegel S, et al
    Immunogenicity of hepatitis B vaccine among hemodialysis patients: Effect of revaccination of non-responders and duration of protection.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  234. SUI Y , Gagnon S, Dzutsev A, Zhu Q, et al
    TLR agonists and/or IL-15 adjuvanted mucosal SIV vaccine reduced gut CD4(+) memory T cell loss in SIVmac251-challenged rhesus macaques.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  235. KAPOSY C
    The influence of the stigma of obesity on H1N1 influenza vaccine sequencing in Canada in 2009.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  236. SCHODEL F
    Immunological Correlates of Vaccine-Derived Protection Fondation Merieux Conference Center 'Les Pensieres' Veyrier-Du-Lac, France, Sept. 20-22, 2010.
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  237. STROMBERG SP , Antia R
    Vaccination by delayed treatment of infection.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  238. EXLEY C
    When an aluminium adjuvant is not an aluminium adjuvant used in human vaccination programmes.
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  239. BIALUK I , Whitney S, Andresen V, Florese RH, et al
    Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  240. OMON E , Damase-Michel C, Hurault-Delarue C, Lacroix I, et al
    Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women: The results of a French prospective descriptive study.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  241. PENFOLD RB , Rusinak D, Lieu T, Shefer A, et al
    Financing and systems barriers to seasonal influenza vaccine delivery in community settings.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  242. ROBBINS SC , Ward K, Skinner SR
    School-based vaccination: A systematic review of process evaluations.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  243. MORAES MP , Segundo FD, Dias CC, Pena L, et al
    Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  244. GARCIA-BASTEIRO AL , Alvarez-Pasquin MJ, Mena G, Llupia A, et al
    A public-professional web-bridge for vaccines and vaccination: User concerns about vaccine safety.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  245. DIEZ-DOMINGO J , Ridao-Lopez M, Gutierrez-Gimeno MV, Puig-Barbera J, et al
    Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain).
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  246. MAMELUND SE , Riise Bergsaker MA
    Vaccine history, gender and influenza vaccination in a household context.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  247. NIU H , Hu L, Li Q, Da Z, et al
    Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  248. PALACHE A
    Seasonal influenza vaccine provision in 157 countries (2004-2009) and the potential influence of national public health policies.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  249. ZHAO Q , Towne V, Brown M, Wang Y, et al
    In-depth process understanding of RECOMBIVAX HB(R) maturation and potential epitope improvements with redox treatment: multifaceted biochemical and immunochemical characterization.
    Vaccine. 2011;29:7936-41.
    PubMed     Text format     Related articles    Abstract available



  250. JAIN R , Dey B, Khera A, Srivastav P, et al
    Over-expression of superoxide dismutase obliterates the protective effect of BCG against tuberculosis by modulating innate and adaptive immune responses.
    Vaccine. 2011;29:8118-25.
    PubMed     Text format     Related articles    Abstract available



  251. SMITH CK , McNeal MM, Meyer NR, Haase S, et al
    Rotavirus shedding in premature infants following first immunization.
    Vaccine. 2011;29:8141-6.
    PubMed     Text format     Related articles    Abstract available



  252. GUPTA P , Singh MK, Singh Y, Gautam V, et al
    Recombinant Shiga toxin B subunit elicits protection against Shiga toxin via mixed Th type immune response in mice.
    Vaccine. 2011;29:8094-100.
    PubMed     Text format     Related articles    Abstract available



  253. MADDEN K , Nan X, Briones R, Waks L, et al
    Sorting through search results: A content analysis of HPV vaccine information online.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  254. STOWE J , Andrews N, Bryan P, Seabroke S, et al
    Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: A database study.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  255. HARDER KM , Cowan S, Eriksen MB, Krarup HB, et al
    Universal screening for hepatitis B among pregnant women led to 96% vaccination coverage among newborns of HBsAg positive mothers in Denmark.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  256. CLUBBE J , Naylor CJ
    Avian metapneumovirus M2:2 protein inhibits replication in Vero cells: Modification facilitates live vaccine development.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  257. KONSTANTYNER T , Taddei JA, Rodrigues LC
    Risk factors for incomplete vaccination in children less than 18 months of age attending the nurseries of day-care centres in Sao Paulo, Brazil.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  258. TOHME RA , Awosika-Olumo D, Nielsen C, Khuwaja S, et al
    Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  259. LIANG Z , Mao Q, Gao Q, Li X, et al
    Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  260. BROWN C , Clayton-Boswell H, Chaves SS, Prill M, et al
    Validity of parental report of influenza vaccination in young children seeking medical care.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  261. WIDGREN K , Simonsen J, Valentiner-Branth P, Molbak K, et al
    Uptake of the human papillomavirus-vaccination within the free-of-charge childhood vaccination programme in Denmark.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  262. POZZA F , Piovesan C, Russo F, Bella A, et al
    Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  263. GRIMPREL E , Laudat F, Patterson S, Baker SA, et al
    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infants.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  264. BOCCALINI S , Azzari C, Resti M, Valleriani C, et al
    Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  265. RIVERA L , Pena LM, Stainier I, Gillard P, et al
    Horizontal transmission of a human rotavirus vaccine strain-A randomized, placebo-controlled study in twins.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  266. JUUL-MADSEN HR , Norup LR, Jorgensen PH, Handberg KJ, et al
    Crosstalk between innate and adaptive immune responses to infectious bronchitis virus after vaccination and challenge of chickens varying in serum mannose-binding lectin concentrations.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  267. POLAND GA , Marcuse EK
    Developing vaccine policy: Attributes of "just policy" and a proposed template to guide decision and policy making.
    Vaccine. 2011;29:7577-8.
    PubMed     Text format     Related articles   



  268. LI RC , Li FX, Li YP, Hou QM, et al
    Antibody persistence at 18-20months of age and safety and immunogenicity of a booster dose of a combined DTaP-IPV//PRP approximately T vaccine compared to separate vaccines (DTaP, PRP approximately T and IPV) following primary vaccination of healthy i
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  269. TANDALE BV , Pawar SD, Mishra AC
    Immunogenicity and safety of pandemic H1N1 2009 vaccine among adults in field use, India.
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  270. SALLERAS M , Dominguez A, Soldevila N, Prat A, et al
    Contacts with children and young people and adult risk of suffering herpes zoster.
    Vaccine. 2011;29:7602-5.
    PubMed     Text format     Related articles    Abstract available



  271. POLEWICZ M , Gracia A, Buchanan R, Strom S, et al
    Influence of maternal antibodies on active pertussis toxoid immunization of neonatal mice and piglets.
    Vaccine. 2011;29:7718-26.
    PubMed     Text format     Related articles    Abstract available



  272. ZHOU L , Yu SJ, Gao W, Yao KH, et al
    Serotype distribution and antibiotic resistance of 140 pneumococcal isolates from pediatric patients with upper respiratory infections in Beijing, 2010.
    Vaccine. 2011;29:7704-10.
    PubMed     Text format     Related articles    Abstract available



  273. ROSELLA L , Groenwold RH, Crowcroft NS
    Assessing the impact of confounding (measured and unmeasured) in a case-control study to examine the increased risk of pandemic A/H1N1 associated with receipt of the 2008-9 seasonal influenza vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  274. PATTERSON M , Poussard A, Taylor K, Seregin A, et al
    Rapid, non-invasive imaging of alphaviral brain infection: Reducing animal numbers and morbidity to identify efficacy of potential vaccines and antivirals.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  275. DAVIS MM , Butchart AT, Wheeler JR, Coleman MS, et al
    Failure-to-success ratios, transition probabilities and phase lengths for prophylactic vaccines versus other pharmaceuticals in the development pipeline.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  276. HARTMAN ZC , Wei J, Glass OK, Guo H, et al
    Increasing vaccine potency through exosome antigen targeting.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  277. DENZLER KL , Babas T, Rippeon A, Huynh T, et al
    Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  278. CATTOLI G , Fusaro A, Monne I, Coven F, et al
    Evidence for differing evolutionary dynamics of A/H5N1 viruses among countries applying or not applying avian influenza vaccination in poultry.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  279. JENIKOVA G , Hruz P, Andersson KM, Tejman-Yarden N, et al
    alpha1-giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine model.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  280. AICHINGER G , Ehrlich HJ, Aaskov JG, Fritsch S, et al
    Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: A randomized trial.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  281. MITKUS RJ , King D, Hess MA, Forshee R, et al
    Updated aluminum pharmacokinetics following infant exposures through diet and vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  282. FREED DC , Towne VM, Casimiro DR, Zhao Q, et al
    Evaluating functional antibodies in rhesus monkeys immunized with hepatitis B virus surface antigen vaccine with novel adjuvant formulations.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  283. SIMON JK , Carter M, Pasetti MF, Sztein MB, et al
    Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  284. DITTRICH S , Hahne S, van Lier A, Kohl R, et al
    Assessment of serological evidence for mumps virus infection in vaccinated children.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  285. BLOCK SL , Yi T, Sheldon E, Dubovsky F, et al
    A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  286. TOBIAS J , Svennerholm AM, Carlin NI, Lebens M, et al
    Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  287. RASHID I , Hedhli D, Moire N, Pierre J, et al
    Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  288. MILLER E , Andrews NJ, Waight PA, Slack MP, et al
    Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  289. SCHWENK R , Lumsden JM, Rein LE, Juompan L, et al
    Immunization with the RTS,S/AS malaria vaccine induces IFN-gamma+CD4 T cells that recognize only discrete regions of the circumsporozoite protein and these specificities are maintained following booster immunizations and challenge.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  290. FANOY E , Cremer J, Ferreira J, Dittrich S, et al
    Transmission of mumps virus from mumps-vaccinated individuals to close contacts.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  291. DENZLER KL , Schriewer J, Parker S, Werner C, et al
    The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virus.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  292. LADHANI S , Oeser C, Sheldon J, Ramsay M, et al
    Immunoglobulin deficiency in children with Hib vaccine failure.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  293. GILDEA S , Arkins S, Walsh C, Cullinane A, et al
    A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings-A randomised blind study.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  294. ABARCA K , Ibanez I, de la Fuente P, Cerda L, et al
    Immunogenicity and tolerability of a paediatric presentation of a virosomal hepatitis A vaccine in Chilean children aged 1-16 years.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  295. HATAKEYAMA S , Iwatsuki-Horimoto K, Okamoto K, Nukui Y, et al
    Unadjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected adults.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  296. PARIANI E , Boschini A, Amendola A, Poletti R, et al
    Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  297. BENITEZ A , Priest JW, Ehigiator HN, McNair N, et al
    Evaluation of DNA encoding acidic ribosomal protein P2 of Cryptosporidium parvum as a potential vaccine candidate for cryptosporidiosis.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  298. SHARMA H , Yadav S, Patil V, Chacko B, et al
    A phase III randomized, controlled study to assess and compare the immunogenicity and tolerability of single and multi-dose vials of DTwP-Hib, a fully liquid quadravalent vaccine and their comparison with TETRAct-Hib vaccine in Indian infants aged 6-1
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  299. YOUNG F , Marra F
    A systematic review of intradermal influenza vaccines.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  300. SKINNER JM , Indrawati L, Cannon J, Blue J, et al
    Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  301. HEIMBURG-MOLINARO J , Lum M, Vijay G, Jain M, et al
    Cancer vaccines and carbohydrate epitopes.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  302. LLUPIA A , Vilella A, Costas L, Diez C, et al
    Can the response to 23-valent pneumococcal vaccine in splenectomised patients be predicted?
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  303. HANAGE WP , Bishop CJ, Lee GM, Lipsitch M, et al
    Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  304. MALTEZOU HC , Wicker S, Borg M, Heininger U, et al
    Vaccination policies for health-care workers in acute health-care facilities in Europe.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  305. NYBLADE L , Singh S, Ashburn K, Brady L, et al
    "Once I begin to participate, people will run away from me": Understanding stigma as a barrier to HIV vaccine research participation in Kenya.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  306. JOKE B , Benson O, Frank H, Pierre VD, et al
    Estimating the age-specific duration of herpes zoster vaccine protection: A matter of model choice?
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  307. GRIVEA IN , Tsantouli AG, Michoula AN, Syrogiannopoulos GA, et al
    Dynamics of Streptococcus pneumoniae nasopharyngeal carriage with high heptavalent pneumococcal conjugate vaccine coverage in Central Greece.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  308. SCHNEIDER-OHRUM K , Giles BM, Weirback HK, Williams BL, et al
    Adjuvants that stimulate TLR3 or NLPR3 pathways enhance the efficiency of influenza virus-like particle vaccines in aged mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  309. SANTIAGO FW , Fitzgerald T, Treanor JJ, Topham DJ, et al
    Vaccination with drifted variants of avian H5 hemagglutinin protein elicits a broadened antibody response that is protective against challenge with homologous or drifted live H5 influenza virus.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  310. WANG RC , Liu ZK, Chen W, Yang Y, et al
    The antitumor immunopreventive effects of a DNA vaccine against CYP26a1 on mouse breast carcinoma.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  311. FRESNAY S , Zhang X, Strome SE, Sewell DA, et al
    Bone marrow vaccination: A novel approach to enhance antigen specific antitumor immunity.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  312. WESTON W , Messier M, Friedland LR, Wu X, et al
    Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  313. COLLER BA , Barrett AD, Thomas SJ
    The development of Dengue vaccines. Introduction.
    Vaccine. 2011;29:7219-20.
    PubMed     Text format     Related articles   



  314. STITTELAAR KJ , Kroeze EJ, Rudenko L, Dhere R, et al
    Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  315. PARK JS , Kim HS, Park HM, Kim CH, et al
    Efficient induction of anti-tumor immunity by a TAT-CEA fusion protein vaccine with poly(I:C) in a murine colorectal tumor model.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  316. BOGAARDS JA , Coupe VM, Meijer CJ, Berkhof J, et al
    The clinical benefit and cost-effectiveness of human papillomavirus vaccination for adult women in the Netherlands.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  317. ZANELLA RC , Bokermann S, Andrade AL, Flannery B, et al
    Changes in serotype distribution of Haemophilus influenzae meningitis isolates identified through laboratory-based surveillance following routine childhood vaccination against H. influenzae type b in Brazil.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  318. JIT M , Yuzbashyan R, Sahakyan G, Avagyan T, et al
    The cost-effectiveness of rotavirus vaccination in Armenia.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available




  319. Vaccine Technology III. Advances in vaccine technology. Proceedings of the ECI Conference. June 6-11. 2011. Puerto Vallarta, Mexico.
    Vaccine. 2011;29:7115-217.
    PubMed     Text format     Related articles   



  320. KHANDKE L , Yang C, Krylova K, Jansen KU, et al
    Preservative of choice for Prev(e)nar 13 in a multi-dose formulation.
    Vaccine. 2011;29:7144-53.
    PubMed     Text format     Related articles    Abstract available



  321. MILLER BL , Ahmed F, Lindley MC, Wortley PM, et al
    Increases in vaccination coverage of healthcare personnel following institutional requirements for influenza vaccination: A national survey of US hospitals.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  322. MEEUSEN EN
    Exploiting mucosal surfaces for the development of mucosal vaccines.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  323. PRECIOSO AR , Miraglia JL, Campos LM, Goulart AC, et al
    A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1) inactivated monovalent vaccines with different adjuvant systems.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  324. HOUWELING H , Spaendonck MC, Paulussen T, Verweij M, et al
    Preparing for the next public debate: Universal vaccination against hepatitis B.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  325. ZHAO K , Shi X, Zhao Y, Wei H, et al
    Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  326. ROBBERSTAD B , Frostad CR, Akselsen PE, Kvaerner KJ, et al
    Economic evaluation of second generation pneumococcal conjugate vaccines in Norway.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  327. CHRISTIAN LM , Iams JD, Porter K, Glaser R, et al
    Inflammatory responses to trivalent influenza virus vaccine among pregnant women.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  328. KUMAR M , Kaur SR, Kariu T, Yang X, et al
    Borrelia burgdorferi BBA52 is a potential target for transmission blocking Lyme disease vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  329. LILA BA , Fatima LD
    Enhanced immune sera and vaccine: Safe approach to treat scorpion envenoming.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  330. STAAT MA , Griffin MR, Donauer S, Edwards KM, et al
    Vaccine effectiveness for laboratory-confirmed influenza in children 6-59 months of age, 2005-2007.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  331. NEIMERT-ANDERSSON T , Hallgren AC, Andersson M, Langeback J, et al
    Improved immune responses in mice using the novel chitosan adjuvant ViscoGel, with a Haemophilus influenzae type b glycoconjugate vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  332. DOMINGUEZ A , Ciruela P, Garcia-Garcia JJ, Moraga F, et al
    Effectiveness of 7-valent pneumococcal conjugate vaccine in the prevention of invasive pneumococcal disease in children aged 7-59 months. A matched case-control study.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  333. KOK G , van Essen GA, Wicker S, Llupia A, et al
    Planning for influenza vaccination in health care workers: An Intervention Mapping approach.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  334. TANUSEPUTRO P , Zagorski B, Chan KJ, Kwong JC, et al
    Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  335. SEPPALA E , Viskari H, Hoppu S, Honkanen H, et al
    Viral interference induced by live attenuated virus vaccine (OPV) can prevent otitis media.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  336. RUSSELL MS , Li C, Larocque L, Wang J, et al
    Rapid and accurate determination of the potency of varicella vaccine by quantitative polymerase chain reaction.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  337. CHERIF MS , Shuaibu MN, Kurosaki T, Helegbe GK, et al
    Immunogenicity of novel nanoparticle-coated MSP-1 C-terminus malaria DNA vaccine using different routes of administration.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  338. ALI M , Sur D, Kim DR, Kanungo S, et al
    Impact of Vi vaccination on spatial patterns of typhoid fever in the slums of Kolkata, India.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  339. WANG Y , Wang M, Wang G, Pang A, et al
    Increased survival time in mice vaccinated with a branched lysine multiple antigenic peptide containing B- and T-cell epitopes from T. gondii antigens.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  340. DRAPER E , Bissett SL, Howell-Jones R, Edwards D, et al
    Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  341. MAREK E , Dergez T, Rebek-Nagy G, Kricskovics A, et al
    Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  342. HARALAMBIEVA IH , Ovsyannikova IG, Umlauf BJ, Vierkant RA, et al
    Genetic polymorphisms in host antiviral genes: Associations with humoral and cellular immunity to measles vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  343. MAHNKE YD , Saqr A, Hazenfeld S, Brady RC, et al
    Age-related changes in durability and function of vaccine-elicited influenza-specific CD4(+) T-cell responses.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  344. MORIYA C , Horiba S, Kurihara K, Kamada T, et al
    Intranasal Sendai viral vector vaccination is more immunogenic than intramuscular under pre-existing anti-vector antibodies.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  345. RUCKINGER S , Dagan R, Albers L, Schonberger K, et al
    Immunogenicity of pneumococcal conjugate vaccines in infants after two or three primary vaccinations: A systematic review and meta-analysis.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  346. DALGLEISH A
    Therapeutic cancer vaccines: Why so few randomised phase III studies reflect the initial optimism of phase II studies.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  347. HURLEY LP , Wortley P, Allison MA, Leary SO, et al
    Seasonal influenza vaccination in adults: Practice and attitudes about collaborative delivery with community vaccinators.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  348. HAMBIDGE SJ , Ross C, McClure D, Glanz J, et al
    Trivalent inactivated influenza vaccine is not associated with sickle cell hospitalizations in adults from a large cohort.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  349. DUCLOS P
    Rubella vaccines: WHO position paper-Recommendations.
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  350. SHOAMANESH A , Traboulsee A
    Acute disseminated encephalomyelitis following influenza vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  351. GIGLIO N , Micone P, Gentile A
    The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America.
    Vaccine. 2011;29 Suppl 3:C35-42.
    PubMed     Text format     Related articles    Abstract available



  352. ANDRADE AL , Toscano CM, Minamisava R, Costa PS, et al
    Pneumococcal disease manifestation in children before and after vaccination: What's new?
    Vaccine. 2011;29 Suppl 3:C2-C14.
    PubMed     Text format     Related articles    Abstract available



  353. GENTILE A , Bazan V
    Prevention of pneumococcal disease through vaccination.
    Vaccine. 2011;29 Suppl 3:C15-25.
    PubMed     Text format     Related articles    Abstract available



  354. HU H , Roth JP, Estevez CN, Zsak L, et al
    Generation and evaluation of a recombinant Newcastle disease virus expressing the glycoprotein (G) of avian metapneumovirus subgroup C as a bivalent vaccine in turkeys.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  355. RODGERS GL , Klugman KP
    The future of pneumococcal disease prevention.
    Vaccine. 2011;29 Suppl 3:C43-8.
    PubMed     Text format     Related articles    Abstract available



  356. ARGUEDAS A , Soley C, Abdelnour A
    Prevenar experience.
    Vaccine. 2011;29 Suppl 3:C26-34.
    PubMed     Text format     Related articles    Abstract available



  357. DAGAN R
    Childhood pneumococcal disease in Latin America: preventable but still deadly.
    Vaccine. 2011;29 Suppl 3:C1.
    PubMed     Text format     Related articles   



  358. VADAPARAMPIL ST , Kahn JA, Salmon D, Lee JH, et al
    Missed clinical opportunities: Provider recommendations for HPV vaccination for 11-12 year old girls are limited.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  359. MORO PL , Yue X, Lewis P, Haber P, et al
    Adverse events after Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  360. DALE JB , Penfound TA, Chiang EY, Walton WJ, et al
    New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  361. WINNOCK M , Bani-Sadr F, Pambrun E, Loko MA, et al
    Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  362. MCEVOY SP
    A retrospective survey of the safety of trivalent influenza vaccine among adults working in healthcare settings in south metropolitan Perth, Western Australia, in 2010.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  363. HARADA Y , Ninomiya-Mori A, Takahashi Y, Shirakura M, et al
    Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  364. RICCI S , Janulczyk R, Gerlini A, Braione V, et al
    The factor H-binding fragment of PspC as a vaccine antigen for the induction of protective humoral immunity against experimental pneumococcal sepsis.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  365. COUSSENS PM , Smith KA, Weber PS, Colvin CJ, et al
    Immortalized chick embryo cell line adapted to serum-free growth conditions and capable of replicating human and reassortant H5N1 influenza strains for vaccine production.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  366. LUBLIN A , Goldenberg D, Rosenbluth E, Heller ED, et al
    Wide-range protection against avian reovirus conferred by vaccination with representatives of four defined genotypes.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  367. MARADEI E , Beascoechea CP, Malirat V, Salgado G, et al
    Characterization of foot-and-mouth disease virus from outbreaks in Ecuador during 2009-2010 and cross-protection studies with the vaccine strain in use in the region.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  368. GUERINO MT , Postol E, Demarchi LM, Martins CO, et al
    HLA class II transgenic mice develop a safe and long lasting immune response against StreptInCor, an anti-group A streptococcus vaccine candidate.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  369. WANG L , Qin Z, Pantin-Jackwood M, Faulkner O, et al
    Development of DIVA (differentiation of infected from vaccinated animals) vaccines utilizing heterologous NA and NS1 protein strategies for the control of triple reassortant H3N2 influenza in turkeys.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  370. LI Y , Reddy K, Reid SM, Cox WJ, et al
    Recombinant herpesvirus of turkeys as a vector-based vaccine against highly pathogenic H7N1 avian influenza and Marek's disease.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  371. GARCIA F , Bernaldo de Quiros JC, Gomez CE, Perdiguero B, et al
    Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  372. SCHULLER E , Klingler A, Dubischar-Kastner K, Dewasthaly S, et al
    Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO((R)).
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  373. GEE J , Naleway A, Shui I, Baggs J, et al
    Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  374. WILSON K , Hawken S, Kwong JC, Deeks S, et al
    Impact of birth weight at term on rates of emergency room visits and hospital admissions following vaccination at 2 months of age.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  375. SAHA A , Chowdhury MI, Khanam F, Bhuiyan MS, et al
    Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  376. SANTAMARIA R , Goulart C, Perciani CT, Barazzone GC, et al
    Humoral immune response of a pneumococcal conjugate vaccine: Capsular polysaccharide serotype 14-Lysine modified PspA.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  377. DELLA CIOPPA G , Vesikari T, Sokal E, Lindert K, et al
    Trivalent and quadrivalent MF59-adjuvanted influenza vaccine in young children: A dose- and schedule-finding study.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  378. FOX CB , Baldwin SL, Duthie MS, Reed SG, et al
    Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  379. OKAYASU H , Sutter R, Czerkinsky C, Ogra PL, et al
    Mucosal immunity and poliovirus vaccines: Impact on wild poliovirus infection and transmission.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  380. VAN GILS EJ , Veenhoven RH, Rodenburg G, Hak E, et al
    Effect of 7-valent pneumococcal conjugate vaccine on nasopharyngeal carriage with Haemophilus influenzae and Moraxella catarrhalis in a randomized controlled trial.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  381. RAINEY JJ , Watkins M, Ryman TK, Sandhu P, et al
    Reasons related to non-vaccination and under-vaccination of children in low and middle income countries: Findings from a systematic review of the published literature, 1999-2009.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  382. WILLIAMS SE , Pahud BA, Vellozzi C, Donofrio PD, et al
    Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  383. HARA M , Hanaoka T, Mizushima T, Honma J, et al
    Diminished immunogenicity to pandemic H1N1 2009 influenza vaccine in subjects with severe motor and intellectual disability.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  384. BARRABEIG I , Rovira A, Munoz P, Batalla J, et al
    MMR vaccine effectiveness in an outbreak that involved day-care and primary schools.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  385. KHEIR AE , Alhaj AA, Ibrahim SA
    The sensitivity of BCG scar as an indicator of previous vaccination among Sudanese infants.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  386. GARLAPATI S , Eng NF, Kiros TG, Kindrachuk J, et al
    Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis.
    Vaccine. 2011;29:6540-8.
    PubMed     Text format     Related articles    Abstract available



  387. PALIWAL PK , Bansal A, Sagi SS, Sairam M, et al
    Intraperitoneal immunization of recombinant HSP70 (DnaK) of Salmonella Typhi induces a predominant Th2 response and protective immunity in mice against lethal Salmonella infection.
    Vaccine. 2011;29:6532-9.
    PubMed     Text format     Related articles    Abstract available



  388. LI J , Xia J, Tan C, Zhou Y, et al
    Evaluation of the immunogenicity and the protective efficacy of a novel identified immunogenic protein, SsPepO, of Streptococcus suis serotype 2.
    Vaccine. 2011;29:6514-9.
    PubMed     Text format     Related articles    Abstract available



  389. FERGUSON M , Wilkinson DE, Heath A, Matejtschuk P, et al
    The first international standard for antibodies to HPV 16.
    Vaccine. 2011;29:6520-6.
    PubMed     Text format     Related articles    Abstract available



  390. LIU KY , Shi Y, Luo P, Yu S, et al
    Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model.
    Vaccine. 2011;29:6679-85.
    PubMed     Text format     Related articles    Abstract available



  391. ZHAO K , Wang H, Wu C
    The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8 T cells are augmented in varying degrees by CpG ODN, PolyI:C and R848.
    Vaccine. 2011;29:6670-8.
    PubMed     Text format     Related articles    Abstract available



  392. GAO X , Cai K, Li T, Wang Q, et al
    Novel fusion protein protects against adherence and toxicity of enterohemorrhagic Escherichia coli O157:H7 in mice.
    Vaccine. 2011;29:6656-63.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  393. KRAUT A , Graff L, McLean D
    Behavioral change with influenza vaccination: Factors influencing increased uptake of the pandemic H1N1 versus seasonal influenza vaccine in health care personnel.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  394. SUN Y , Li HY, Tian DY, Han QY, et al
    A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  395. TANG A , Li F, Freed DC, Finnefrock AC, et al
    A novel high-throughput neutralization assay for supporting clinical evaluations of human cytomegalovirus vaccines.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  396. VAN REGENMORTEL MH
    Two meanings of reverse vaccinology and the empirical nature of vaccine science.
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  397. MAHMUD SM , Hammond G, Elliott L, Hilderman T, et al
    Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: Population-based case-control study.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  398. MITRAKRISHNAN S , Ranjanie G, Thirunavakarasu T, Manjula C, et al
    Seizures and retrograde amnesia with cerebrospinal fluid changes following H1N1 influenza vaccination.
    Vaccine. 2011;29:6369-70.
    PubMed     Text format     Related articles    Abstract available



  399. ARJONA MA , Elaziz KM, Lanzas JM, Allam MF, et al
    Coverage and side effects of influenza A(H1N1) 2009 monovalent vaccine among primary health care workers.
    Vaccine. 2011;29:6366-8.
    PubMed     Text format     Related articles    Abstract available



  400. POLAND CM , Poland GA
    Vaccine education spectrum disorder: the importance of incorporating psychological and cognitive models into vaccine education.
    Vaccine. 2011;29:6145-8.
    PubMed     Text format     Related articles   



  401. ZHENG H , Chen Y, Wang F, Gong X, et al
    Comparing live attenuated and inactivated hepatitis A vaccines: An immunogenicity study after one single dose.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  402. HARALAMBIEVA IH , Ovsyannikova IG, Kennedy RB, Vierkant RA, et al
    Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  403. ANDREWS NJ , Walker WT, Finn A, Heath PT, et al
    Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  404. MULLOOLY JP , Schuler R, Mesa J, Drew L, et al
    Wheezing lower respiratory disease and vaccination of premature infants.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  405. LEE AW , Vesikari T, Gilbert CL, Klopfer SO, et al
    Immunogenicity and safety of a Haemophilus influenzae B (Hib)-hepatitis B vaccine with a modified process hepatitis B component administered with concomitant pneumococcal conjugate vaccine to infants.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  406. TOUSSAINT NC , Maman Y, Kohlbacher O, Louzoun Y, et al
    Universal peptide vaccines - Optimal peptide vaccine design based on viral sequence conservation.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  407. ANDREWS N , Stowe J, Al-Shahi Salman R, Miller E, et al
    Guillain-Barre syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: Self-controlled case series.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  408. REN J , Yang L, Xu H, Zhang Y, et al
    CpG oligodeoxynucleotide and montanide ISA 206 adjuvant combination augments the immune responses of a recombinant FMDV vaccine in cattle.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  409. JACOBSON RM , Ovsyannikova IG, Vierkant RA, Shane Pankratz V, et al
    Human leukocyte antigen associations with humoral and cellular immunity following a second dose of measles-containing vaccine: Persistence, dampening, and extinction of associations found after a first dose.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  410. GIAMBI C , Donati S, Declich S, Salmaso S, et al
    Estimated acceptance of HPV vaccination among Italian women aged 18-26 years.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  411. COOPER C , Thorne A
    Influenza vaccine Oculorespiratory syndrome incidence is reduced in HIV.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  412. PRIDGEON JW , Klesius PH
    Development and efficacy of novobiocin and rifampicin-resistant Aeromonas hydrophila as novel vaccines in channel catfish and Nile tilapia.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  413. SHEA KM , Weycker D, Stevenson AE, Strutton DR, et al
    Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  414. NIEVES W , Asakrah S, Qazi O, Brown KA, et al
    A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  415. PARVEEN S , Kaur S, David SA, Kenney JL, et al
    Evaluation of growth based rapid microbiological methods for sterility testing of vaccines and other biological products.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  416. LEEB A , Carcione D, Richmond PC, Jacoby P, et al
    Reactogenicity of two 2010 trivalent inactivated influenza vaccine formulations in adults.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  417. BOWMAN BN , McAdam PR, Vivona S, Zhang J, et al
    Improving reverse vaccinology with a machine learning approach.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  418. ZHANG W , Xue T, Wu X, Zhang P, et al
    Increase in viral yield in eggs and MDCK cells of reassortant H5N1 vaccine candidate viruses caused by insertion of 38 amino acids into the NA stalk.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  419. LAM SK
    Preparing for introduction of a dengue vaccine: Recommendations from the 1st Dengue v2V Asia-Pacific Meeting.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  420. TAITEL M , Cohen E, Duncan I, Pegus C, et al
    Pharmacists as providers: Targeting pneumococcal vaccinations to high risk populations.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  421. COX RJ , Pedersen G, Madhun AS, Svindland S, et al
    Evaluation of a virosomal H5N1 vaccine formulated with Matrix M adjuvant in a phase I clinical trial.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  422. ATMAR RL , Keitel WA, Quarles JM, Cate TR, et al
    Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  423. GABITZSCH ES , Xu Y, Balint JP Jr, Balcaitis S, et al
    Induction and comparison of SIV immunity in Ad5 naive and Ad5 immune non-human primates using an Ad5 [E1-, E2b-] based vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  424. NEWALL AT , Creighton P, Philp DJ, Wood JG, et al
    The potential cost-effectiveness of infant pneumococcal vaccines in Australia.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  425. WHELDON CW , Daley EM, Buhi ER, Nyitray AG, et al
    Health beliefs and attitudes associated with HPV vaccine intention among young gay and bisexual men in the southeastern United States.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  426. LEE S , Park WB, Shin KH, Ahn DH, et al
    Immunogenicity and safety of a single intramuscular dose of a diphtheria-tetanus toxoid (Td) vaccine (GC1107) in Korean adults.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  427. PETTI S , Messano GA, Polimeni A
    Dentists' awareness toward vaccine preventable diseases.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  428. AMODIO E , Tramuto F, Maringhini G, Asciutto R, et al
    Are medical residents a "core group" for future improvement of influenza vaccination coverage in health-care workers? A study among medical residents at the University Hospital of Palermo (Sicily).
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  429. LEFEVERE E , Hens N, Theeten H, Van den Bosch K, et al
    Like mother, like daughter? Mother's history of cervical cancer screening and daughter's Human Papillomavirus vaccine uptake in Flanders (Belgium).
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  430. GIRARD MP , Katz JM, Pervikov Y, Hombach J, et al
    Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  431. FOWLER VL , Bashiruddin JB, Maree FF, Mutowembwa P, et al
    Foot-and-mouth disease marker vaccine: Cattle protection with a partial VP1 G-H loop deleted virus antigen.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  432. WU J , Ma H, Qu Q, Zhou WJ, et al
    Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  433. SCHMEINK CE
    Co-administration of human papillomavirus-16/18 AS04-adjuvanted vaccine with hepatitis B vaccine: Randomized study in healthy girls.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  434. CASTANEDA-ORJUELA C , Alvis-Guzman N, Paternina AJ, De la Hoz-Restrepo F, et al
    Cost-effectiveness of the introduction of the pneumococcal polysaccharide vaccine in elderly Colombian population.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  435. LENG J , Delgado HS, Kavita U, Jacobs A, et al
    Efficacy of a vaccine that links viral epitopes to flagellin in protecting aged mice from influenza viral infection.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  436. BLAZEVIC V , Lappalainen S, Nurminen K, Huhti L, et al
    Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  437. NISHIZAWA T , Takami I, Yang M, Oh MJ, et al
    Live vaccine of viral hemorrhagic septicemia virus (VHSV) for Japanese flounder at fish rearing temperature of 21 degrees C instead of Poly(I:C) administration.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  438. RORKE-ADAMS LB , Evans G, Weibel RE, Johann-Liang R, et al
    Neuropathology of vaccination in infants and children.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  439. ESPOSITO S , Daleno C, Picciolli I, Tagliaferri L, et al
    Immunogenicity and safety of intradermal influenza vaccine in children.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  440. FRANCIS SA , Battle-Fisher M, Liverpool J, Hipple L, et al
    A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  441. TUELLS J
    An appeal to include the History of Vaccinology.
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  442. WEST NP , Thomson SA, Triccas JA, Medveczky CJ, et al
    Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  443. MONSONEGO J
    Response to Letter to the Editor by Tsu et al. "Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine"
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  444. LOEW-BASELLI A , Poellabauer EM, Pavlova BG, Fritsch S, et al
    Prevention of tick-borne encephalitis by FSME-IMMUN((R)) vaccines: Review of a clinical development programme.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  445. AN SJ , Yoon YK, Kothari S, Kothari N, et al
    Physico-chemical properties of Salmonella typhi Vi polysaccharide-diphtheria toxoid conjugate vaccines affect immunogenicity.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  446. ZHANG T , Yang H, Wang R, Xu K, et al
    Oral administration of myostatin-specific whole recombinant yeast Saccharomyces cerevisiae vaccine increases body weight and muscle composition in mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  447. MICHIELS B , Govaerts F, Remmen R, Vermeire E, et al
    A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  448. DENZLER KL , Rice AD, Macneill AL, Fukushima N, et al
    The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  449. XIA M , Tan M, Wei C, Zhong W, et al
    A candidate dual vaccine against influenza and noroviruses.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  450. RAND CM , Humiston SG, Schaffer SJ, Albertin CS, et al
    Parent and adolescent perspectives about adolescent vaccine delivery: Practical considerations for vaccine communication.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  451. GOFF SL , Mazor KM, Gagne SJ, Corey KC, et al
    Vaccine counseling: A content analysis of patient-physician discussions regarding human papilloma virus vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  452. HENKEL JS , Tepp WH, Przedpelski A, Fritz RB, et al
    Subunit vaccine efficacy against Botulinum neurotoxin subtypes.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  453. VOJNOV L , Bean AT, Peterson EJ, Chiuchiolo MJ, et al
    DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4(+) T cells, but few subdominant epitope-specific CD8(+) T cells.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  454. JONES JC , Settles EW, Brandt CR, Schultz-Cherry S, et al
    Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  455. LI K , Luo J, Wang C, He H, et al
    alpha-Galactosylceramide potently augments M2e-induced protective immunity against highly pathogenic H5N1 avian influenza virus infection in mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  456. TREANOR JJ , Sahly HE, King J, Graham I, et al
    Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok((R))) against influenza in healthy adults: A randomized, placebo-controlled trial.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  457. MA H , Shaheduzzaman S, Willliams DK, Gao Y, et al
    Investigations of porcine circovirus type 1 (PCV1) in vaccine-related and other cell lines.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  458. LU YC , Li MC, Chen YM, Chu CY, et al
    DNA vaccine encoding type IV pilin of Actinobacillus pleuropneumoniae induces strong immune response but confers limited protective efficacy against serotype 2 challenge.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  459. CHOE YJ , Cho H, Kim SN, Bae GR, et al
    Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003-2010.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  460. RAMSEY MA , Marczinski CA
    College students' perceptions of H1N1 flu risk and attitudes toward vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  461. PINTO VB , Moran EE, Cruz F, Wang XM, et al
    An experimental outer membrane vesicle vaccine from N. meningitidis serogroup B strains that induces serum bactericidal activity to multiple serogroups.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  462. NGUYEN CT , Kim SY, Kim MS, Lee SE, et al
    Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Vaccine. 2011;29:5731-9.
    PubMed     Text format     Related articles    Abstract available



  463. RODRIGUEZ MA , Gonzalez AV, Gavin MA, Martinez FM, et al
    Invasive pneumococcal disease: association between serotype, clinical presentation and lethality.
    Vaccine. 2011;29:5740-6.
    PubMed     Text format     Related articles    Abstract available



  464. GIL-PRIETO R , Garcia-Garcia L, Alvaro-Meca A, Gonzalez-Escalada A, et al
    The burden of hospitalizations for meningococcal infection in Spain (1997-2008).
    Vaccine. 2011;29:5765-70.
    PubMed     Text format     Related articles    Abstract available



  465. WIJNANS L , de Bie S, Dieleman J, Bonhoeffer J, et al
    Safety of pandemic H1N1 vaccines in children and adolescents.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  466. TILSON L , Jit M, Schmitz S, Walsh C, et al
    Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  467. CHAN TC , Hung IF, Luk JK, Shea YF, et al
    Efficacy of dual vaccination of pandemic H1N1 2009 influenza and seasonal influenza on institutionalized elderly: A one-year prospective cohort study.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  468. LAU CY , Swann EM, Singh S, Kafaar Z, et al
    Conceptual framework for behavioral and social science in HIV vaccine clinical research.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  469. JONES FR , Gabitzsch ES, Xu Y, Balint JP, et al
    Prevention of influenza virus shedding and protection from lethal H1N1 challenge using a consensus 2009 H1N1 HA and NA adenovirus vector vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  470. PLOIN D , Schwarzenbach F, Dubray C, Nicolas JF, et al
    Echographic measurement of skin thickness in sites suitable for intradermal vaccine injection in infants and children.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  471. SCOTT P , Rutjes AW, Bermetz L, Robert N, et al
    Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: A systematic review and meta-analysis.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  472. JASPERS L , Budiningsih S, Wolterbeek R, Henderson FC, et al
    Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: A cross-sectional study.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  473. STAM J , van Stuijvenberg M, Garssen J, Knipping K, et al
    A mixture of three prebiotics does not affect vaccine specific antibody responses in healthy term infants in the first year of life.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  474. PIER GB
    Refers to: J.-P. Rasigade, N. Sicot, F. Laurent, G. Lina, F. Vandenesch, J. Etienne, A history of Panton-Valentine leukocidin (PVL)-associated infection protects against death in PVL-associated pneumonia, Vaccine 29 (25) (2011) 4185-4186.
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  475. HEIKKINEN T , Heinonen S
    Effectiveness and safety of influenza vaccination in children: European perspective.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  476. BLANCHARD-ROHNER G , Siegrist CA
    Vaccination during pregnancy to protect infants against influenza: Why and why not?
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  477. RIMMELZWAAN GF , Bodewes R, Osterhaus AD
    Vaccination strategies to protect children against seasonal and pandemic influenza.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  478. ESPOSITO S , Principi N
    Different influenza vaccine formulations and adjuvants for childhood influenza vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  479. NICHOL KL
    Cost-effectiveness and socio-economic aspects of childhood influenza vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  480. GRANSTROM M , Voordouw AC
    Registration of influenza vaccines for children in Europe.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  481. WICK DA , Webb JR
    A novel, broad spectrum therapeutic HPV vaccine targeting the E7 proteins of HPV16, 18, 31, 45 and 52 that elicits potent E7-specific CD8T cell immunity and regression of large, established, E7-expressing TC-1 tumors.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  482. WINDISH HP , Duthie MS, Ireton G, Lucas E, et al
    Protection of mice from Mycobacterium tuberculosis by ID87/GLA-SE, a novel tuberculosis subunit vaccine candidate.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  483. TRIMIS G , Koutsoumbari I, Kottaridi C, Palaiologou N, et al
    Hospital-based surveillance of rotavirus gastroenteritis in the era of limited vaccine uptake through the private sector.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  484. LANTHIER PA , Huston GE, Moquin A, Eaton SM, et al
    Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  485. MARUGAN-HERNANDEZ V , Ortega-Mora LM, Aguado-Martinez A, Jimenez-Ruiz E, et al
    Transgenic Neospora caninum strains constitutively expressing the bradyzoite NcSAG4 protein proved to be safe and conferred significant levels of protection against vertical transmission when used as live vaccines in mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  486. BHATTACHARYA D , Bensaci M, Luker KE, Luker G, et al
    Development of a baited oral vaccine for use in reservoir-targeted strategies against Lyme disease.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  487. LOPEZ-MACIAS C , Ferat-Osorio E, Tenorio-Calvol A, Isibasi A, et al
    Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  488. ZHU CL , Liu P, Chen T, Ni Z, et al
    Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  489. CHESSON HW , Ekwueme DU, Saraiya M, Dunne EF, et al
    The cost-effectiveness of male HPV vaccination in the United States.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  490. CHENG AC , Kotsimbos T, Kelly HA, Irving LB, et al
    Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: A test-negative case control study.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  491. LEBENS M , Karlsson SL, Kallgard S, Blomquist M, et al
    Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  492. GRIMPREL E , Wysocki J, Boisnard F, Thomas S, et al
    Immunogenicity and safety of fully liquid DTaP(5)-IPV-Hib compared with DTaP(3)-IPV/Hib when both coadministered with a heptavalent pneumococcal conjugate vaccine (PCV7) at 2, 3, 4, and 12 to 18 months of age: A phase III, single-blind, randomised, co
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  493. LIN HX , Huang DY, Wang Y, Lu CP, et al
    A novel vaccine against Streptococcus equi ssp. zooepidemicus infections: The recombinant swinepox virus expressing M-like protein.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  494. BERNSTEIN DI , Sahly HM, Keitel WA, Wolff M, et al
    Safety and immunogenicity of a candidate parvovirus B19 vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  495. GU J , Ning Y, Wang H, Xiao D, et al
    Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  496. GORDON D , Waller J, Marlow LA
    Attitudes to HPV vaccination among mothers in the British Jewish community: Reasons for accepting or declining the vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  497. YUAN T , Li J, Zhang Y, Wang Y, et al
    Putative rhesus macaque germline predecessors of human broadly HIV-neutralizing antibodies: Differences from the human counterparts and implications for HIV-1 vaccine development.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  498. CHOR JS , Pada SK, Stephenson I, Goggins WB, et al
    Seasonal influenza vaccination predicts pandemic H1N1 vaccination uptake among healthcare workers in three countries.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  499. PATOIS E , Capelle MA, Gurny R, Arvinte T, et al
    Stability of seasonal influenza vaccines investigated by spectroscopy and microscopy methods.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  500. VILA-CORCOLES A , Ochoa-Gondar O, Gomez-Bertomeu F, Raga-Luria X, et al
    Invasive pneumococcal disease in Catalonian elderly people, 2002-2009: Serotype coverage for different anti-pneumococcal vaccine formulations at the beginning of the new conjugate vaccines era.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  501. LIAKOU CD , Askiti V, Mitsioni A, Stefanidis CJ, et al
    Safety, immunogenicity and kinetics of immune response to 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  502. PATHANIA S , Kumar P, Devi LG, Kumar D, et al
    Preliminary assessment of binary ethylenimine inactivated and saponized cutaneous warts (BPV-2) therapeutic vaccine for enzootic bovine haematuria in hill cows.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  503. WIGGAN O , Livengood JA, Silengo SJ, Kinney RM, et al
    Novel formulations enhance the thermal stability of live-attenuated flavivirus vaccines.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  504. OZEKI Y , Hirayama Y, Takii T, Yamamoto S, et al
    Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guerin.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  505. ARNOLD R , Galloway Y, McNicholas A, O'Hallahan J, et al
    Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  506. LAGLER H , Wenisch JM, Tobudic S, Gualdoni GA, et al
    Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: Immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  507. OLUGBILE S , Villard V, Bertholet S, Jafarshad A, et al
    Malaria vaccine candidate: Design of a multivalent subunit alpha-helical coiled coil poly-epitope.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  508. ABBAS MA , Spackman E, Fouchier R, Smith D, et al
    H7 avian influenza virus vaccines protect chickens against challenge with antigenically diverse isolates.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  509. LAN J , Gao Z, Xiong H, Chuai X, et al
    Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  510. CEHOVIN A , Kroll JS, Pelicic V
    Testing the vaccine potential of PilV, PilX and ComP, minor subunits of Neisseria meningitidis type IV pili.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  511. BERNET J , Ahmad M, Mullick J, Panse Y, et al
    Disabling complement regulatory activities of vaccinia virus complement control protein reduces vaccinia virus pathogenicity.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  512. SZYNCZEWSKA E , Chlebna-Sokol D
    Immunogenicity and safety of heptavalent conjugate vaccine against Streptococcus pneumoniae in pre-term Polish infants.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  513. KUETHER G , Dietrich B, Smith T, Peter C, et al
    Atraumatic osteonecrosis of the humeral head after influenza A-(H1N1) v-2009 vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  514. HALPERIN SA , McNeil S, Langley J, Blatter M, et al
    Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4-5 years after a previous dose.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  515. HENDRIKX LH , Schure RM, Ozturk K, de Rond LG, et al
    Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  516. CAO Y , Faisal SM, Yan W, Chang YC, et al
    Evaluation of novel fusion proteins derived from extracellular matrix binding domains of LigB as vaccine candidates against leptospirosis in a hamster model.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  517. TOGASHI T
    My continuing efforts toward the eradication of the vaccine-preventable diseases from Japan.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  518. MIZUNO D , Kimoto T, Takei T, Fukuta A, et al
    Surfactant protein C is an essential constituent for mucosal adjuvanticity of Surfacten, acting as an antigen delivery vehicle and inducing both local and systemic immunity.
    Vaccine. 2011;29:5368-78.
    PubMed     Text format     Related articles    Abstract available



  519. JACUPS SP , Cheng A
    The epidemiology of community acquired bacteremic pneumonia, due to Streptococcus pneumoniae, in the Top End of the Northern Territory, Australia--over 22 years.
    Vaccine. 2011;29:5386-92.
    PubMed     Text format     Related articles    Abstract available



  520. ZENG J , Deng G, Wang J, Zhou J, et al
    Potential protective immunogenicity of recombinant Clostridium perfringens alpha-beta2-beta1 fusion toxin in mice, sows and cows.
    Vaccine. 2011;29:5459-66.
    PubMed     Text format     Related articles    Abstract available



  521. COLOMBINI A , Badolo O, Gessner BD, Jaillard P, et al
    Costs and impact of meningitis epidemics for the public health system in Burkina Faso.
    Vaccine. 2011;29:5474-80.
    PubMed     Text format     Related articles    Abstract available



  522. WHELAN AO , Coad M, Upadhyay BL, Clifford DJ, et al
    Lack of correlation between BCG-induced tuberculin skin test sensitisation and protective immunity in cattle.
    Vaccine. 2011;29:5453-8.
    PubMed     Text format     Related articles    Abstract available



  523. ISHIKAWA T , Wang G, Widman DG, Infante E, et al
    Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  524. JAHANGIRI A , Rasooli I, Gargari SL, Owlia P, et al
    An in silico DNA vaccine against Listeria monocytogenes.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  525. GARCIA F , Routy JP
    Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  526. FRIESEN J , Matuschewski K
    Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  527. REY-LADINO J , Ross AG, Cripps AW, McManus DP, et al
    Natural products and the search for novel vaccine adjuvants.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  528. RIDDLE MS , Kaminski RW, Williams C, Porter C, et al
    Safety, and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  529. MADHI SA , Violari A, Klugman KP, Lin G, et al
    Inferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  530. DEXHEIMER JW , Talbot TR 3rd, Ye F, Shyr Y, et al
    A computerized pneumococcal vaccination reminder system in the adult emergency department.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  531. BERNSTEIN DI , Falloon J, Yi T
    A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in healthy infants.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  532. LU PJ , Byrd KK, Murphy TV, Weinbaum C, et al
    Hepatitis B vaccination coverage among high-risk adults 18-49 years, U.S., 2009.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  533. SCHMITZ J , Roehrig J, Barrett A, Hombach J, et al
    Next generation dengue vaccines: A review of candidates in preclinical development.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  534. DURBIN AP , Kirkpatrick BD, Pierce KK, Schmidt AC, et al
    Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  535. DANKO JR , Beckett CG, Porter KR
    Development of dengue DNA vaccines.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  536. WEIL-OLIVIER C , Lina B
    Vaccination coverage with seasonal and pandemic influenza vaccines in children in France, 2009-2010 season.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  537. OSORIO JE , Huang CY, Kinney RM, Stinchcomb DT, et al
    Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  538. COLLER BA , Clements DE, Bett AJ, Sagar SL, et al
    The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  539. DUCLOS P
    Vaccines against tick-borne encephalitis: WHO position paper - Recommendations.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  540. CAGLE C , To TL, Nguyen T, Wasilenko J, et al
    Pekin and Muscovy ducks respond differently to vaccination with a H5N1 highly pathogenic avian influenza (HPAI) commercial inactivated vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  541. QUENEE LE , Ciletti NA, Elli D, Hermanas TM, et al
    Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  542. SAFARI D , Dekker HA, de Jong B, Rijkers GT, et al
    Antibody- and cell-mediated immune responses to a synthetic oligosaccharide conjugate vaccine after booster immunization.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  543. SUN F , Zhang Y, Tian D, Zheng M, et al
    Responses after one dose of a monovalent influenza A (H1N1) 2009 inactivated vaccine in Chinese population-A practical observation.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  544. BELONGIA EA , Kieke BA, Donahue JG, Coleman LA, et al
    Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: Comparison of interim and final results.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  545. CAREY A , Cunningham K, Andrew D, Hafner L, et al
    A comparison of the effects of a chlamydial vaccine administered during or after a C. muridarum urogenital infection of female mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  546. FOMSGAARD A , Karlsson I, Gram G, Schou C, et al
    Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  547. MO A , Musselli C, Chen H, Pappas J, et al
    A heat shock protein based polyvalent vaccine targeting HSV-2: CD4(+) and CD8(+) cellular immunity and protective efficacy.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  548. LEE H , Cho SN, Kim HJ, Anh YM, et al
    Evaluation of cell-mediated immune responses to two BCG vaccination regimes in young children in South Korea.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  549. GRABENSTEIN JD , Manoff SB
    Pneumococcal vaccines in adults: Assessing the evolving evidence.
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  550. RAY P , Black S, Shinefield H, Dillon A, et al
    Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  551. OPEL DJ , Taylor JA, Mangione-Smith R, Solomon C, et al
    Validity and reliability of a survey to identify vaccine-hesitant parents.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  552. UGEN KE , Weiner DB
    DNA vaccines 2010: A gumbo of accomplishment and excitement in New Orleans.
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  553. MONTO AS , Black S, Plotkin SA, Orenstein WA, et al
    Response to the 2009 pandemic: Effect on influenza control in wealthy and poor countries.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  554. HANKINS CA , Glasser JW, Chen RT
    Modeling the impact of RV144-like vaccines on HIV transmission.
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  555. TALBIRD S , Knerer G, Hausdorff W, Taylor T, et al
    Reply to Strutton et al.: Response to "Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries"
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  556. BARRETO ML , Pereira SM, Pilger D, Cruz AA, et al
    Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial.
    Vaccine. 2011;29:4875-7.
    PubMed     Text format     Related articles    Abstract available



  557. SHARMA VK , Dean-Nystrom EA, Casey TA
    Evaluation of hha and hha sepB mutant strains of Escherichia coli O157:H7 as bacterins for reducing E. coli O157:H7 shedding in cattle.
    Vaccine. 2011;29:5078-86.
    PubMed     Text format     Related articles    Abstract available



  558. LIU YV , Massare MJ, Barnard DL, Kort T, et al
    Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  559. SCOTT PD , Meng B, Marriott AC, Easton AJ, et al
    Defective interfering influenza virus confers only short-lived protection against influenza virus disease: Evidence for a role for adaptive immunity in DI virus-mediated protection in vivo.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  560. BISH A , Yardley L, Nicoll A, Michie S, et al
    Factors associated with uptake of vaccination against pandemic influenza: A systematic review.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  561. PAILLET C , Forno G, Soldano N, Kratje R, et al
    Statistical optimization of influenza H1N1 production from batch cultures of suspension Vero cells (sVero).
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available



  562. CHEN RT , Hu DJ, Dunne E, Shaw M, et al
    Preparing for the availability of a partially effective HIV vaccine: Lessons from other licensed vaccines.
    Vaccine. 2011.
    PubMed     Text format     Related articles   



  563. GUY B , Barrere B, Malinowski C, Saville M, et al
    From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine.
    Vaccine. 2011.